Technology

Masimo announced the CE Mark and full market release of MightySat Rx fingertip pulse oximeter for clinical use in CE countries. The device uses Masimo’s SET Measure-Through Motion and Low Perfusion pulse oximetry.

Home July 08, 2015
Home
Technology

Biosense Webster Inc. announced the launch of the Confidense Module, an innovative technology that streamlines the creation of real-time 3-D maps of a patient’s cardiac structures during catheter ablation procedures. Utilizing an advanced, proprietary algorithm, the module enhances the process for validating information, or “points,” acquired during multi-electrode mapping, enabling electrophysiologists to focus their time and expertise on the most relevant data during the mapping process.

Home July 07, 2015
Home
ASE, echocardiography, hypertension, document, EACVI, JASE, Thomas H. Marwick
Feature | Cardiovascular Ultrasound

A new document from the American Society of Echocardiography (ASE) provides detailed guidance for clinicians on how to use echocardiography to see the full picture of the condition of patients with hypertension. The paper, Recommendations on the Use of Echocardiography in Adult Hypertension: A Report from the European Association of Cardiovascular Imaging (EACVI) and the American Society of Echocardiography (ASE) is a joint project between ASE and the European Association of Cardiovascular Imaging (EACVI) and will appear in the July issue of the Journal of the American Society of Echocardiography (JASE).

Home July 07, 2015
Home
News | Antiplatelet and Anticoagulation Therapies

Results from an interim analysis of the Phase III RE-VERSE AD patient study demonstrate that 5 g of idarucizumab immediately reversed the anticoagulant effect of dabigatran (Pradaxa) in patients requiring urgent anticoagulant reversal. No safety concerns relating to idarucizumab were identified. The results have been simultaneously published in the New England Journal of Medicine (NEJM) and presented at the International Society of Thrombosis and Haemostasis 2015 Congress in Toronto, Canada.

Home July 07, 2015
Home
Case Study | Radiation Dose Management

Safety accidents drive up costs, damage reputations and lower patient satisfaction scores. For instance, if a patient falls off a system's table after being sedated and is badly injured, it can result in significant repercussions for the provider. This type of scenario is rare, but still causes concern for health systems nationwide.

Home July 07, 2015
Home
Feature | Cardiovascular Ultrasound | Dave Fornell, DAIC Editor

Here are a few observations on cardiovascular ultrasound advances I made while attending the 2015 American Society of Echocardiography (ASE) annual meeting in June:

Home July 07, 2015
Home
News | Heart Failure

DC Devices Inc. announced that it has completed enrollment and implants in the REDUCE LAP-HF trial, an open label, multi-center, single-arm study of the InterAtrial Shunt Device (IASD). The IASD is a transcatheter device for the treatment of diastolic heart failure (DHF), which is also known as heart failure with preserved ejection fraction (HFpEF).

Home July 06, 2015
Home
News | Nuclear Imaging

Medraysintell released its updated World Market Report and Directory on Nuclear Medicine, Edition 2015, in late June, providing a description and analysis of the latest developments in nuclear medicine. The 920-page document covers 335 radiopharmaceuticals and radionuclides and 160 companies and institutions active in nuclear medicine.

Home July 06, 2015
Home
News | Cardiac Diagnostics

University of Southampton scientists have discovered a link between coronary heart disease and osteoporosis, suggesting both conditions could have similar causes.

Home July 02, 2015
Home
Boston Scientific, Emblem, S-ICD, UNTOUCHED study, TV-ICDs, MADIT-RIT study
Feature | Implantable Cardioverter Defibrillator (ICD)

Boston Scientific has initiated a worldwide study to evaluate the rate and causes of shocks for patients implanted with the Emblem subcutaneous implantable defibrillator (S-ICD). The device is indicated for primary prevention of sudden cardiac death in the setting of severely reduced cardiac function (left ventricular ejection fraction </= 35 percent).

Home July 02, 2015
Home
News | Endovascular Aortic Repair

Medtronic plc announced it has acquired the assets of Aptus Endosystems Inc., a privately held medical device company focused on developing advanced technology for endovascular aneurysm repair (EVAR) and thoracic endovascular aneurysm repair (TEVAR). Medtronic completed its acquisition of the assets of Aptus Endosystems in a transaction valued at approximately $110 million. Additional terms of the acquisition were not disclosed.

Home July 02, 2015
Home
Ilumien Optis, 3D OCT, 3-D OCT
Feature | Intravascular Imaging | Dave Fornell

Angiography alone for procedural image guidance in the catheterization lab is sometimes not enough, and it is helpful to augment X-ray lumen imaging with intravascular ultrasound (IVUS) or optical coherence tomography (OCT) to visualize the soft tissue morphology.

Home July 02, 2015
Home
FFR, fractional flow reserve, Opsens Medical
Feature | FFR Technologies | Dave Fornell

Key to ongoing U.S. healthcare reform are efforts to reduce costs by eliminating unnecessary medical procedures and using information technology (IT) to justify costs that are incurred to make providers more accountable. Key medical societies in each subspecialty will be responsible for what standards of care should be set and what guidelines should be followed. In the cath lab, fractional flow reserve (FFR) is already viewed as the gold standard for determining the hemodynamic impact of coronary lesions, acting as a gatekeeper to whether a patient is stented or receives medical therapy alone. For this reason, FFR is already being predicted as the measurement of record that will be required in documentation for stent reimbursement in the future.

Home July 01, 2015
Home
radiation exposure, CT, X-ray, cancer, James Welsh, Jeffry Siegel, Loyola. Vivian Fornell
Feature | Radiation Dose Management

In recent years, there has been widespread media coverage of studies purporting to show that radiation from X-rays, computed tomography (CT) scans and other medical imaging causes cancer. But such studies have serious flaws, including their reliance on an unproven statistical model, according to a recent article in the journal Technology in Cancer Research & Treatment. Corresponding author is Loyola University Medical Center radiation oncologist James Welsh, M.D., MS.

Home July 01, 2015
Home
Technology

The American College of Cardiology (ACC) Statin Intolerance App is now available to help guide clinicians through the process of managing and treating patients who report muscle symptoms while on statin therapy.

Home July 01, 2015
Home
Subscribe Now